Revenue,
USD USD 1.61 Bn
Forecast Year,
USD USD 2.65 Bn
CAGR, 2025 -
5.13%
Report Coverage
Worldwide
Catheter Related Bloodstream Infection Market Size Analysis
Catheter Related Bloodstream Infection Market Size By Treatment Type 2024 to 2034 (USD )
| Treatment Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-microbial Agents | 1046.50 | 1101.88 | 1160.18 | 1221.57 | 1286.21 | 1354.26 | 1425.90 | 1501.34 | 1580.76 | 1664.38 | 1752.41 |
| Antibiotic Lock Therapy | 563.50 | 590.71 | 619.24 | 649.14 | 680.47 | 713.31 | 747.73 | 783.80 | 821.61 | 861.23 | 902.76 |
Catheter Related Bloodstream Infection Market Size By Source of Infection 2024 to 2034 (USD )
| Source of Infection | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Coagulase-negative Staphylococcus | 402.50 | 424.84 | 448.41 | 473.29 | 499.54 | 527.23 | 556.45 | 587.28 | 619.81 | 654.13 | 690.34 |
| S. aureus | 322.00 | 340.21 | 359.44 | 379.75 | 401.20 | 423.85 | 447.77 | 473.02 | 499.69 | 527.85 | 557.59 |
| Enteric Gram-negative Bacilli | 289.80 | 303.82 | 318.52 | 333.92 | 350.07 | 366.99 | 384.73 | 403.33 | 422.82 | 443.24 | 464.65 |
| Yeasts | 193.20 | 202.26 | 211.75 | 221.68 | 232.07 | 242.94 | 254.31 | 266.22 | 278.67 | 291.71 | 305.34 |
| Enterococci & Streptococci | 161.00 | 170.11 | 179.72 | 189.88 | 200.60 | 211.93 | 223.88 | 236.51 | 249.85 | 263.93 | 278.79 |
| Pseudomonas | 128.80 | 133.71 | 138.79 | 144.04 | 149.47 | 155.07 | 160.85 | 166.82 | 172.97 | 179.32 | 185.86 |
| Others | 112.70 | 117.64 | 122.78 | 128.14 | 133.73 | 139.56 | 145.63 | 151.96 | 158.56 | 165.43 | 172.59 |
Catheter Related Bloodstream Infection Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 885.50 | 932.62 | 982.24 | 1034.50 | 1089.54 | 1147.50 | 1208.54 | 1272.82 | 1340.52 | 1411.81 | 1486.90 |
| Retail Pharmacies | 483.00 | 506.93 | 532.05 | 558.41 | 586.07 | 615.10 | 645.57 | 677.54 | 711.10 | 746.32 | 783.28 |
| Online Pharmacies | 241.50 | 253.04 | 265.13 | 277.80 | 291.07 | 304.97 | 319.52 | 334.77 | 350.75 | 367.48 | 385.00 |
Catheter Related Bloodstream Infection Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 611.80 | 644.03 | 677.96 | 713.67 | 751.27 | 790.84 | 832.50 | 876.35 | 922.51 | 971.10 | 1022.24 |
| Europe | 434.70 | 457.85 | 482.22 | 507.90 | 534.94 | 563.41 | 593.40 | 624.99 | 658.25 | 693.28 | 730.17 |
| Asia-Pacific | 354.20 | 373.22 | 393.25 | 414.36 | 436.60 | 460.03 | 484.72 | 510.73 | 538.13 | 567.00 | 597.41 |
| Latin America | 112.70 | 117.64 | 122.78 | 128.14 | 133.73 | 139.56 | 145.63 | 151.96 | 158.56 | 165.43 | 172.59 |
| Middle East & Africa | 96.60 | 99.86 | 103.21 | 106.63 | 110.13 | 113.72 | 117.38 | 121.11 | 124.92 | 128.81 | 132.76 |
Catheter Related Bloodstream Infection Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com